Dr Animesh Saha

Menu

Publications

  • Can Dosimetry Affect Overall Survival in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR)? An Analysis of 1300 Patients. A. Saha, M. Beasley, K. Clarke, P. Jain, P. Dickinson, M. Snee, P. Murray, M. Teo, S.L. Rodda, J. Lilley, K.N. Franks. Int J Radiat Oncol Biol Phys. September 1, 2019Volume 105, Issue 1, Supplement, Page E529. DOI: https://doi.org/10.1016/j.ijrobp.2019.06.2433.
  • Setting up a lung Stereotactic Body Radiotherapy (SBRT) service in a tertiary centre in eastern India– The process, quality assurance and early experience. Shrimali RK, Saha A, Arun B, Prasath S, Nallathambi C, Bhoumik S, Mallick I, Achari RB, Chatterjee Ahead of print in Journal of cancer research and therapeutics. DOI: 10.4103/jcrt.JCRT_427_18.
  • Radical radiotherapy or chemoradiotherapy for inoperable locally advanced non-small-cell lung cancer (NSCLC) - Analysis of patient profile, treatment approaches and outcomes of 213 patients at a tertiary cancer centre. Shrimali RK, Nallathambi C, Saha A, Das A, Prasath S, Mahata A, Arun B, Mallick I, Achari R, Dabkara D, Thambudorai R, Chatterjee S. Indian J Cancer. 2018 Apr-Jun; 55(2):125-133. doi: 10.4103/ijc.IJC_469_17.
  • A Prospective Study of an Offline Matching Protocol for Head and Neck Cancer on Helical Tomotherapy: The F5 Study. I. Mallick, A. Saha, S. Chatterjee. . Int J Radiat Oncol. October 1, 2017Volume 99, Issue 2, Supplement, Page S71. DOI: https://doi.org/10.1016/j.ijrobp.2017.06.173.
  • Acute toxicity and in-vivo dosimetry of a two week hypofractionated schedule within the HYPORT study. A. Saha, G. Goswami, S. Mandal, A. Mahata, D. Midha, R. Ahmed, S. Agarwal, S. Ray, J. Das, S.S. Datta, S. Sinha, S. Chatterjee. Radiother Oncol. May 2017Volume 123, Supplement 1, Page S970. DOI: https://doi.org/10.1016/S0167-8140 (17)32126-6.
  • High-dose Neural Stem Cell Radiation May Not Improve Survival in Glioblastoma. R. Achari *, M. Arunsingh, R.K. Badgami, A. Saha, S. Chatterjee, R.K. Shrimali, I. Mallick, B. Arun. Clinical Oncology (2017) 1-9. http://dx.doi.org/10.1016/j.clon.2017.01.010.
  • Quality Assurance and Acute Toxicities of a 2 Week Hypofractionated Palliative Radiotherapy Schedule used in a Prospective Phase I/II Study (HYPORT Study). S. Chatterjee, A. Saha, R.K. Badgami, P. Sen, D. Midha, S. Sinha, S. Agarwal, S. Ray, J. Das, S.S. Datta, A. Mahata, S. Mondal, R. Ahmed. Clinical Oncology. March 2017, Volume 29, Issue 3, Page e74. DOI: https://doi.org/10.1016/j.clon.2016.10.011.
  • Agrawal S, Banswal L, Saha A, Arun I, Datta SS, Chatterjee S, Ahmed R.Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer – a Single Centre Study. (PPLB – 01). Indian J Surg Oncol. 2016 Dec;7(4):397-406. Epub 2016 Apr 23.
  • A. Saha, I. Mallick, P. Das, R.K. Shrimali, R. Achari, S. Chatterjee. Evaluating the Need for Daily Image Guidance in Head and Neck Cancers Treated with Helical Tomotherapy: A Retrospective Analysis of Large Number of Daily Imaging-based Corrections. Clin Oncol 28 (2016) 178-184.
  • Expression of immunohistochemical markers in locally advanced breast carcinoma and their use as predictors of pathological response: A prospective analysis of a retrospective cohort. (EXIPAR study). Animesh Saha , Sonali Nayak , Sanjit Agarwal , Indu Arun , Rosina Ahmed , Sanjoy ChatterjeeMayur Parihar , Subir Sinha . J Clin Oncol. 2015, 33, no. 15_suppl. DOI: 10.1200/jco.2015.33.15_suppl.e11509.
  • Chatterjee S, Saha A, Arun I, Nayak SS, Sinha S, Agrawal S, Parihar M, Ahmed R. Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators? Breast Cancer: Targets and Therapy 2015:7 381–388.
  • Saha A, Mahata A, Shrimali R, Achari R, Mallick I, Chatterjee S. Helical tomotherapy based intensity modulated radiotherapy for the management of difficult clinical situations in breast cancer. Clin Cancer Investig J 2015;4:543-47. DOI: 10.4103/2278-0513.159788.
  • Saha A, Ghosh SK, Roy C, Saha ML, Choudhury KB, Chatterjee K. A randomized controlled pilot study to compare capecitabine-oxaliplatin with 5FU-leucovorin as neoadjuvant concurrent chemoradiation in locally advanced adenocarcinoma of rectum. J Cancer Res Ther. 2015 Jan-Mar;11(1):88-93. doi: 10.4103/0973-1482.150341.
  • Roy C, Choudhury KB, Ghosh A, Saha A, Joarder R, Akhil SP. Feasibility of organ preservation in muscle-invasive transitional cell carcinoma bladder: A single institutional approach. Clin Cancer Investig J 2015; 4:175-82.
  • Saha A, Ghosh SK, Roy C, Kayal P. Treatment outcomes in patients with multiple brain metastases: A prospective randomized study. Clin Cancer Investig J 2014;3:269-275.
  • Saha A, Roy C, Sarkar R, Kayal P. Rhabdomyosarcoma thigh in a 45-year-old male: A rare presentation. Clin Cancer Investig J 2014;3:429-31.
  • Kayal PK, Saha A, Dastidar AG, Mahata A, Das A, Sarkar R. A randomized comparative study between neoadjuvant 5-fluorouracil and leukovorin versus 5-fluorouracil and cisplatin along with concurrent radiation in locally advanced carcinoma rectum. Clin Cancer Investig J 2014;3:32-7.
  • Saha A, Roy C, Ghosh SK. Squamous cell carcinoma kidney in a 29-year-old male: A case report with review of literature. Clin Cancer Investig J 2013;2:347-9.
  • Saha A, Ghosh SK, Roy C, Choudhury KB, Chakrabarty B, Sarkar R. Demographic and clinical profile of patients with brain metastases: A retrospective study. Asian J Neurosurg 2013;8:157-61.
  • Roy C, Choudhury KB, Pal M, Saha A, Bag S, Banerjee C. Adjuvant chemotherapy with six cycles of AC regimen verses three cycles of AC regimen followed by three cycles paclitaxel in node positive breast cancer. Indian J cancer 2012;49:266-71.
  • Roy C, Saha A, Roy S, Ghosh A. Extranodal rosai dorfman disease presenting as spinal extradural lesion: a case report with review of literature. J can res ther 2012;8:647-9.